HARTFORD, Conn., March 21, 2016 -- Shipman & Goodwin LLP, one of Connecticut’s largest law firms with 180 attorneys, has opened an office in New York City. Joining the firm in the new office are Michael T. Conway and Stephen I. Siller, both senior-level lawyers formerly of LeClairRyan in New York, NY.
Shipman & Goodwin’s newest office is at 400 Park Ave. - 5th Floor in Manhattan. The firm’s other locations are in Hartford, Stamford, Greenwich, New Haven and Lakeville, Conn., and in Washington D.C.
“Our firm’s new Manhattan office strategically solidifies our goal of expanding our presence in the nation’s largest city,” explains Alan E. Lieberman, Managing Partner of Shipman & Goodwin. “This new office also will enhance the firm’s existing work for clients in the areas of mergers and acquisitions, bankruptcy, finance, litigation, tax and trusts and estates.”
“We are thrilled to be able to establish a permanent presence in the heart of the active midtown real estate market, as this enables our team to bring greater resources and efficiencies to our clients,” says Mr. Kent S. Nevins, who practices in the firm’s New York City and Stamford, Conn. offices. Notably, in February, Shipman & Goodwin concluded a significant transaction for a major New York City developer in its acquisition of the fee interest in the iconic Lipstick Building at 885 Third Ave.
“We are very pleased to welcome new partners Michael T. Conway and Stephen I. Siller,” states Mr. Lieberman. “Both are highly respected, experienced attorneys who will be tremendous assets as we grow our New York area business.” Mr. Conway's practice is focused primarily on litigation on behalf of financial institutions, companies, officers and directors. A large portion of his practice involves advising franchisors and franchisees. Mr. Siller’s expertise is in corporate law, mergers and acquisitions, ranging from multinational banks and manufacturing companies to firms in the hospitality, logistics, distribution, commodities trading, staffing, real estate, industrial gas, media, equipment leasing, and consulting fields.
The newest office of Shipman & Goodwin LLP is at 400 Park Ave. - 5th Floor, New York, NY 10022.
Phone: 212-376-3010; and Fax. 212-376-3024. Website: www.shipmangoodwin.com
Shipman & Goodwin LLP is a multi-practice law firm with 180 attorneys and offices in Hartford, Stamford, Greenwich, New Haven and Lakeville, Conn., in Washington D.C., and now in New York, NY. The 96-year-old firm represents many leading businesses, institutions, individuals, and government entities across the U.S. For more information, visit www.shipmangoodwin.com.
Media Contacts: Jill A. Mastrianni, Chief Marketing Officer Shipman & Goodwin LLP 860-251-5090, [email protected] Laura Soll, Public Relations 860-688-4499, [email protected]


Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



